These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9087158)

  • 1. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
    Chung JH; deTineo ML; Naclerio RM; Sorrentino JV; Winslow CM; Baroody FM
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):307-12. PubMed ID: 9087158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis.
    Baroody FM; Foster KA; Markaryan A; deTineo M; Naclerio RM
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):194-9. PubMed ID: 18426137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
    Stuebner P; Horak F; Zieglmayer R; Arnáiz E; Leuratti C; Pérez I; Izquierdo I
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):37-44. PubMed ID: 16440531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal azelastine on the response to nasal allergen challenge.
    Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
    Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM; Mucha SM; Detineo M; Naclerio RM
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of nasal allergen challenge in evaluating the efficacy of intranasal corticosteroid treatment.
    Proud D; Riker DK; Togias A
    Clin Exp Allergy; 2010 May; 40(5):738-44. PubMed ID: 20337650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients.
    Gentile DA; Yokitis J; Angelini BL; Doyle WJ; Skoner DP
    Ann Allergy Asthma Immunol; 2001 May; 86(5):531-6. PubMed ID: 11379804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
    Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
    J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
    Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
    Greiff L; Persson CG; Andersson M
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study.
    Meltzer EO; Casale TB; Gold MS; O'Connor R; Reitberg D; del Rio E; Weiler JM; Weiler K
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.